Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,573
Closed -$475K 1154
2025
Q4
$475K Buy
37,573
+9,491
+34% +$140K ﹤0.01% 582
2025
Q3
$432K Buy
+28,082
New +$453K ﹤0.01% 561

Other funds holding RXO

Freestone Grove Partners's RXO Position: Q1 2026 in Review

Freestone Grove Partners sold out of RXO (RXO) in Q1 2026, closing a stake of 37,573 shares — an estimated $475K sold.

Freestone Grove Partners first reported a position in RXO in Q3 2025 and held it in 2 quarters. The position peaked at $475K in Q4 2025. 274 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Freestone Grove Partners reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 37,573 RXO shares in Q1 2026, an estimated $475K.
  • Freestone Grove Partners first reported a position in RXO in Q3 2025 and held it in 2 quarters.
  • Freestone Grove Partners's RXO position peaked at $475K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.